Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience

Purpose: The purpose of this study was to identify prognostic factors associated with the successful outcome of endometrial cancer (EC) in women aged ≤40 years. Methods: This was a retrospective cohort study. The medical records of all women aged ≤ 40 years with EC diagnosed on endometrial curettag...

Full description

Bibliographic Details
Main Authors: Gülşah Selvi Demirtaş, Mehmet Gökçü
Format: Article
Language:English
Published: Rabia Yılmaz 2021-05-01
Series:Journal of Contemporary Medicine
Subjects:
Online Access:https://dergipark.org.tr/tr/pub/jcm/issue/60386/887727
id doaj-a0106beffbf64a9497c7d9a3f292e2ac
record_format Article
spelling doaj-a0106beffbf64a9497c7d9a3f292e2ac2021-08-29T10:32:42ZengRabia YılmazJournal of Contemporary Medicine2667-71802021-05-0111335736310.16899/jcm.8877271809Endometrial Cancer in 40 Years Old or Younger: A Single Center ExperienceGülşah Selvi Demirtaş0Mehmet Gökçü1izmir tepecik eğitim ve araştırma hastanesi jinekolojik onkoloji bölümüizmir tepecik eğitim ve araştırma hastanesi jinekolojik onkoloji bölümüPurpose: The purpose of this study was to identify prognostic factors associated with the successful outcome of endometrial cancer (EC) in women aged ≤40 years. Methods: This was a retrospective cohort study. The medical records of all women aged ≤ 40 years with EC diagnosed on endometrial curettage between 1995 and 2020 were reviewed. Patients who underwent hysterectomy and whose final histopathological evaluation was made in our hospital, or who were evaluated by the members of the tumor board and followed up in our hospital, were included in the study. Results: Median follow-up was 79 months (range 9-192). 42 of 44 patients underwent surgical intervention. 33,4%(n: 14) underwent total abdominal hysterectomy (TAH), bilateral salpingo-oophorectomy (BSO), and pelvic paraaortic lymph node dissection (PPLND). 61.9% (n:26) underwent TAH BSO, and PLND. In one patient (2,4 %) only TAH and in the other patient (2,4%) TAH BSO was performed. Medical treatment was administered to 2 patients who desired to preserve their fertility and had grade 1 endometrioid adenocarcinoma without any evidence of myometrial invasion and a comprehensive evaluation showed no evidence of extra-uterine disease. 26 (59,1%) patients had grade 1, 15(34,1%) had grade 2, and 3(6,8%) had grade 3 adenocarcinoma. CA 125 ≥35 IU/ml was statistically associated with lymph node metastasis (p=0,004), ˃ 50% myometrial invasion (p=0,044), and advanced-stage disease (p=0,048). Conclusions: CA 125 ≥35 IU/ml was statistically associated with lymph node metastasis, deep myometrial invasion, and advanced-stage disease in EC patients ≤ 40 years of age.https://dergipark.org.tr/tr/pub/jcm/issue/60386/887727ca 125, endometrial cancertreatmentyoung patientsca 125endometri̇um kanseri̇tedavi̇genç hastalar
collection DOAJ
language English
format Article
sources DOAJ
author Gülşah Selvi Demirtaş
Mehmet Gökçü
spellingShingle Gülşah Selvi Demirtaş
Mehmet Gökçü
Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
Journal of Contemporary Medicine
ca 125
, endometrial cancer
treatment
young patients
ca 125
endometri̇um kanseri̇
tedavi̇
genç hastalar
author_facet Gülşah Selvi Demirtaş
Mehmet Gökçü
author_sort Gülşah Selvi Demirtaş
title Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
title_short Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
title_full Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
title_fullStr Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
title_full_unstemmed Endometrial Cancer in 40 Years Old or Younger: A Single Center Experience
title_sort endometrial cancer in 40 years old or younger: a single center experience
publisher Rabia Yılmaz
series Journal of Contemporary Medicine
issn 2667-7180
publishDate 2021-05-01
description Purpose: The purpose of this study was to identify prognostic factors associated with the successful outcome of endometrial cancer (EC) in women aged ≤40 years. Methods: This was a retrospective cohort study. The medical records of all women aged ≤ 40 years with EC diagnosed on endometrial curettage between 1995 and 2020 were reviewed. Patients who underwent hysterectomy and whose final histopathological evaluation was made in our hospital, or who were evaluated by the members of the tumor board and followed up in our hospital, were included in the study. Results: Median follow-up was 79 months (range 9-192). 42 of 44 patients underwent surgical intervention. 33,4%(n: 14) underwent total abdominal hysterectomy (TAH), bilateral salpingo-oophorectomy (BSO), and pelvic paraaortic lymph node dissection (PPLND). 61.9% (n:26) underwent TAH BSO, and PLND. In one patient (2,4 %) only TAH and in the other patient (2,4%) TAH BSO was performed. Medical treatment was administered to 2 patients who desired to preserve their fertility and had grade 1 endometrioid adenocarcinoma without any evidence of myometrial invasion and a comprehensive evaluation showed no evidence of extra-uterine disease. 26 (59,1%) patients had grade 1, 15(34,1%) had grade 2, and 3(6,8%) had grade 3 adenocarcinoma. CA 125 ≥35 IU/ml was statistically associated with lymph node metastasis (p=0,004), ˃ 50% myometrial invasion (p=0,044), and advanced-stage disease (p=0,048). Conclusions: CA 125 ≥35 IU/ml was statistically associated with lymph node metastasis, deep myometrial invasion, and advanced-stage disease in EC patients ≤ 40 years of age.
topic ca 125
, endometrial cancer
treatment
young patients
ca 125
endometri̇um kanseri̇
tedavi̇
genç hastalar
url https://dergipark.org.tr/tr/pub/jcm/issue/60386/887727
work_keys_str_mv AT gulsahselvidemirtas endometrialcancerin40yearsoldoryoungerasinglecenterexperience
AT mehmetgokcu endometrialcancerin40yearsoldoryoungerasinglecenterexperience
_version_ 1721187287875715072